Insider Makes Significant Stock buy in Amicus Therapeutics (FOLD) Shares Extends the Trend of Last 90 Days

Tuesday, March 06, 2018 10:15 PM ET

Insider Makes Significant Stock buy in Amicus Therapeutics (FOLD) Shares Extends the Trend of Last 90 Days

One Amicus Therapeutics insider — Perceptive Advisors Llc, 10% Owner — today, purchased 200,000 shares having a market value of approximately $2,779,000, as disclosed in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 100,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 300,000 shares and have averaged 150,000 shares per transaction over this time period.

Insider buy/sell trading at Amicus Therapeutics is higher than the 121 peer company average over the last 90-day period. The Pharmaceuticals peer group saw 83 buy/sell trades during this period for an average of 0.7 transactions per company. The number of shares per buy/sell trade for Amicus Therapeutics insiders was also higher. Within the peer group there were 2,598,449 shares purchased and 4,014,981 shares sold with company insiders having sold 17,067 shares on average.

The data used in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.